Trials were included if they compared any GLP-1RA medication to placebo or another active treatment and reported validated measures of binge eating or related eating behaviors, such as loss-of-control eating and disinhibited eating
If your concentration is 1 mg/mL, 0.25 mg is 0.25 mL the quarter mark on a 1 mL syringe
Common Side Effects Facial flushing or warmth Nausea, stomach discomfort Chest tightness or pressure (usually dose/rate dependent) Headache Fatigue after administration Injection site discomfort, redness, or swelling Mild dizziness Seek Medical Attention For Severe chest pain or difficulty breathing Signs of allergic reaction: hives, facial swelling, throat tightness Fainting or severe dizziness Use in Pregnancy and Breastfeeding The safety of NAD+ therapy during pregnancy and breastfeeding has not been established
Gently swirl the vial to mix the contents
Sublingual semaglutide and oral semaglutide drops are alternative delivery methods that some providers prescribe
The complete peptide storage guide covers these considerations in more detail
